#Nanobodies have the potential to be developed into treatment and immunity against #SARS_CoV2 and its novel escape mutant. Thanks to their small size they can bind to the virus in more places than regular #antibodies.
#Nanobodies are able to access #epitopes that are inaccessible to conventional #antibodies. It should be possible to develop nanobodies that recognize novel epitopes that retain broad neutralizing activity.
